Strategic partnerships Target large and mid size pharma firms seeking to accelerate biologics programs by partnering with Just Biotherapeutics for end to end design to manufacturing capabilities. Leverage Just's collaboration history, including Teva, to demonstrate value in biomanufacturing depth and speed to clinic.

End to end Position Just as an integrated partner that spans molecule design to manufacturing plant readiness, appealing to startups and mid sized biotechs looking to streamline vendor ecosystems and shorten development timelines.

Digital analytics edge Highlight the use of analytics and programming tools to optimize process development, scale up, and manufacturing efficiency, offering clients data driven decision making and potential improvements in yield and quality.

Licensing partnerships Explore licensing partnerships and technology integrations with cell line development and bioprocess tool providers to expand Just's platform, creating a broader ecosystem for clients and expanding collaboration opportunities.

Growth potential Leverage Seattle location and a compact, skilled team to target growth stage biotechs and regional West Coast players, positioning Just as a nimble partner with access to talent and potential funding momentum.